Sprinklr Announces Third Quarter Fiscal 2022 Results

Go back to Sprinklr Announces Third Quarter Fiscal 2022 Results
Cardium Therapeutics, Inc. (NYSE: CXM) Delayed: 7.28 +0.08 (1.11%)
Previous Close $7.20    52 Week High $1.44 
Open $7.18    52 Week Low $0.06 
Day High $7.32    P/E N/A 
Day Low $7.12    EPS $-1.24 
Volume 823,266